Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Worldwide, over 300 million electrocardiograms (EKGs) are performed each year, with one-third of those taking place in the ...

Professor Allan Lawrie discusses the future of personalised cardiovascular disease detection and monitoring and wearable ...

If there are complexities or greater risks, or labour has been artificially induced, continuous monitoring is recommended.

More than 80 percent of NHL and AHL teams are using equipment that helps them specialize practices and recovery periods.